Montréal is the largest city in Canada's Québec province. It’s set on an island in the Saint Lawrence River and named after Mt. Royal, the triple-peaked hill at its heart. Its boroughs, many of which were once independent cities, include neighbourhoods ranging from cobblestoned, French colonial Vieux-Montréal – with the Gothic Revival Notre-Dame Basilica at its centre – to bohemian Plateau. ― Google

During the past decade, Universite de Montreal conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 6 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 2 clinical trials were completed. i.e. 13.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universite de Montreal" #1 sponsor was "Université de Montréal" with 24 trials, followed by "University of British Columbia" with 4 trials sponsored, "University of Alberta" with 3 trials sponsored, "Centre hospitalier de l'Université de Montréal (CHUM)" with 2 trials sponsored and "Ception Therapeutics" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universite de Montreal" #1 collaborator was "Université de Montréal" with 6 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 5 trials as a collaborator, "McGill University Health Centre/Research Institute of the McGill University Health Centre" with 3 trials as a collaborator, "Alberta Children's Hospital" with 2 trials as a collaborator and "Children's Hospital of Eastern Ontario" with 2 trials as a collaborator. Other collaborators include 67 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "Universite de Montreal" are "Obstructive Sleep Apnea" (3 trials), "Stroke" (3 trials), "Vestibulodynia" (3 trials), "Eosinophilic Esophagitis" (2 trials) and "Jaw, Edentulous" (2 trials). Many other conditions were trialed in "Universite de Montreal" in a lesser frequency.

Most popular intervention types in "Universite de Montreal" are "Drug" (19 trials), "Other" (16 trials), "Behavioral" (10 trials), "Procedure" (9 trials) and "Device" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ABH001" (1 trials), "Acute moderate to vigorous exercise performed at a specific moment of the day" (1 trials), "Aquablation" (1 trials) and "Argon laser trabeculoplasty" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universite de Montreal" are 47 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Universite de Montreal". undefined are not yet recruiting, 10 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Universite de Montreal, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Universite de Montreal, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 32 trials that are defined as “Not Applicable".

Universite de Montreal has several departments that took part in Clinical trials: "Hopital Sacre-Coeur Research Centre" - 4 trials, "Universite de Montreal - Hopital Maisonneuve-Rosemont" - 3 trials, "Hopital Sacre Coeur & Universite de Montreal" - 2 trials, "Dr Emil Toma / Hotel Dieu de Montreal" - 2 trials, "Clinique d'orthodontie de l'Université de Montréal" - 2 trials